Name: Charming Medical Limited (MCTA) Financial Statements
Creator: FinSpry

Charming Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Charming Medical Limited income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023
Period Ending	Mar 2025	Dec 2024	Mar 2023
Revenue & Gross Profit
Revenue	6.22	6.22	3.53
Cost of Revenue	2.04	2.04	0.05
Gross Profit	4.18	4.18	3.48
Operating Expenses
Research & Development	0.00	0.00	0.00
Selling, General & Administrative	2.32	2.32	3.65
Operating Expenses	2.57	2.79	3.86
Operating Income	1.62	1.39	-0.38
Other Income/Expense
Interest Income	0.06	0.06	0.01
Interest Expense	0.02	0.02	-0.02
Other Income/Expense	-0.01	0.05	-0.03
Income
Income Before Tax	1.44	1.44	-0.42
Income Tax Expense	0.24	0.24	-0.08
Net Income	1.20	1.20	-0.31
Net Income - Continuous Operations	1.20	1.20	-0.34
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	1.72	1.72	-0.17
EBIT	1.46	1.17	-0.38
Depreciation & Amortization	0.26	0.26	0.21
Earnings Per Share
Basic EPS	-	-	-
Diluted EPS	-	-	-
Basic Shares Outstanding	15.34	16.94	15.34
Diluted Shares Outstanding	15.34	16.94	15.34